Bronislawa Szarzynska

Bronia joined MNM in June 2022. She coordinates MNM’s laboratory work focused on drug target identification and characterization. Bronia has a PhD in medical sciences from the Institute of Human Genetics of the Polish Academy of Sciences in Poznan. She participated in numerous scientific projects and internships (University Medical Center for Children and Adolescents, Heidelberg, Germany; Ghent University, Belgium; University of New Mexico, USA). She has a publication track record on research of the molecular basis of head and neck cancers and leukemia. Before joining MNM, Bronia worked for a biopharma company on the development of gene therapy products.